Luye Pharma Group Ltd.

This early-stage study tests a new drug called LY03021 in 98 healthy adults aged 18 to 45. The main goal is to check safety and how the body processes the drug. It is a first step toward possibly treating depression, but does not involve patients with depression yet.

This study tests three different doses of a new drug called LY01021 in about 90 women undergoing IVF or ICSI. The goal is to find the best dose to control hormone levels and improve the number of eggs retrieved, fertilization rates, and pregnancy rates. Participants are married w…

This study looks at whether eating food changes how the body absorbs a new medicine called LY03020, which is being developed for schizophrenia and Alzheimer's-related psychosis. Sixteen healthy adults will take the drug once with food and once without, and researchers will measur…